AAPL280.22+5.07 (+1.84%) ▲|ABBV246.52+3.38 (+1.39%) ▲|ABT94.23+0.99 (+1.06%) ▲|ACN128.62+2.80 (+2.23%) ▲|ADBE201.36+7.95 (+4.11%) ▲|AMAT645.36-22.64 (-3.39%) ▼|AMD519.28-13.29 (-2.50%) ▼|AMGN356.42+3.60 (+1.02%) ▲|AMT175.38+6.66 (+3.95%) ▲|AMZN230.59+3.58 (+1.58%) ▲|AVGO370.54-8.37 (-2.21%) ▼|AXP341.58-0.88 (-0.26%) ▼|BA219.05+0.93 (+0.43%) ▲|BAC57.94-0.25 (-0.43%) ▼|BKNG182.53+5.48 (+3.10%) ▲|BLK976.79+4.87 (+0.50%) ▲|BMY57.05+1.66 (+2.99%) ▲|BNY143.86-1.57 (-1.08%) ▼|BRK-B496.42+8.61 (+1.76%) ▲|C141.90-3.08 (-2.12%) ▼|CAT1,007.50-49.51 (-4.68%) ▼|CL90.79-0.27 (-0.30%) ▼|CMCSA23.18+0.49 (+2.16%) ▲|COF205.01+0.11 (+0.05%) ▲|COP105.29-1.12 (-1.05%) ▼|COST954.42+12.18 (+1.29%) ▲|CRM157.67+7.48 (+4.98%) ▲|CSCO115.96-3.01 (-2.53%) ▼|CVS104.52-0.14 (-0.13%) ▼|CVX170.67-1.57 (-0.91%) ▼|DE626.19-4.57 (-0.72%) ▼|DHR193.81+1.00 (+0.52%) ▲|DIS98.77+0.72 (+0.73%) ▲|DUK127.90+0.79 (+0.62%) ▲|EMR144.22-1.12 (-0.77%) ▼|FDX323.00-6.45 (-1.96%) ▼|GD347.34+2.64 (+0.77%) ▲|GE368.94-2.42 (-0.65%) ▼|GEV1,054.09-31.38 (-2.89%) ▼|GILD126.85+3.01 (+2.43%) ▲|GM78.52-0.01 (-0.01%) ▼|GOOG340.48-1.71 (-0.50%) ▼|GOOGL341.51-2.20 (-0.64%) ▼|GS1,030.82-34.27 (-3.22%) ▼|HD348.34+3.34 (+0.97%) ▲|HON230.53-0.71 (-0.31%) ▼|IBM270.59+12.32 (+4.77%) ▲|INTC128.35-4.53 (-3.41%) ▼|INTU269.61+14.54 (+5.70%) ▲|ISRG404.89+5.20 (+1.30%) ▲|JNJ253.59+8.71 (+3.56%) ▲|JPM330.08-5.04 (-1.50%) ▼|KO82.02+1.60 (+1.98%) ▲|LIN520.15-2.13 (-0.41%) ▼|LLY1,206.45+78.76 (+6.98%) ▲|LMT511.56+6.54 (+1.30%) ▲|LOW221.63-0.31 (-0.14%) ▼|LRCX381.07-20.75 (-5.16%) ▼|MA502.09+13.17 (+2.69%) ▲|MCD268.05+3.51 (+1.33%) ▲|MDLZ61.45+0.25 (+0.41%) ▲|MDT80.81+1.01 (+1.27%) ▲|META555.47+12.60 (+2.32%) ▲|MMM165.31-2.67 (-1.59%) ▼|MO73.40+0.19 (+0.26%) ▲|MRK127.63+2.18 (+1.74%) ▲|MS213.82-7.22 (-3.27%) ▼|MSFT371.69+18.86 (+5.35%) ▲|MU1,152.96-60.60 (-4.99%) ▼|NEE87.81+0.11 (+0.12%) ▲|NFLX73.89+2.99 (+4.21%) ▲|NKE40.96+0.06 (+0.15%) ▲|NOW97.65+8.13 (+9.08%) ▲|NVDA195.23-0.51 (-0.26%) ▼|ORCL150.85-1.61 (-1.06%) ▼|PEP141.32+1.80 (+1.29%) ▲|PFE24.19+0.52 (+2.18%) ▲|PG148.75+0.25 (+0.17%) ▲|PLTR113.72+6.45 (+6.01%) ▲|PM181.08+2.15 (+1.20%) ▲|QCOM197.23-7.68 (-3.75%) ▼|RTX189.39+2.80 (+1.50%) ▲|SBUX104.38+1.22 (+1.18%) ▲|SCHW89.83+0.39 (+0.44%) ▲|SO96.85+0.94 (+0.97%) ▲|SPG226.62+1.13 (+0.50%) ▲|T22.57+0.15 (+0.67%) ▲|TMO504.71-1.04 (-0.21%) ▼|TMUS183.34+1.77 (+0.98%) ▲|TSLA383.64+8.52 (+2.27%) ▲|TXN293.90-17.91 (-5.74%) ▼|UBER76.14+3.89 (+5.38%) ▲|UNH425.04+9.51 (+2.29%) ▲|UNP269.45+1.72 (+0.64%) ▲|UPS108.60-0.72 (-0.65%) ▼|USB61.06-0.16 (-0.25%) ▼|V337.94+7.42 (+2.24%) ▲|VZ46.48+0.41 (+0.89%) ▲|WFC84.74-0.01 (-0.01%) ▼|WMT116.91+1.13 (+0.98%) ▲|XOM136.49-1.06 (-0.77%) ▼|AAPL280.22+5.07 (+1.84%) ▲|ABBV246.52+3.38 (+1.39%) ▲|ABT94.23+0.99 (+1.06%) ▲|ACN128.62+2.80 (+2.23%) ▲|ADBE201.36+7.95 (+4.11%) ▲|AMAT645.36-22.64 (-3.39%) ▼|AMD519.28-13.29 (-2.50%) ▼|AMGN356.42+3.60 (+1.02%) ▲|AMT175.38+6.66 (+3.95%) ▲|AMZN230.59+3.58 (+1.58%) ▲|AVGO370.54-8.37 (-2.21%) ▼|AXP341.58-0.88 (-0.26%) ▼|BA219.05+0.93 (+0.43%) ▲|BAC57.94-0.25 (-0.43%) ▼|BKNG182.53+5.48 (+3.10%) ▲|BLK976.79+4.87 (+0.50%) ▲|BMY57.05+1.66 (+2.99%) ▲|BNY143.86-1.57 (-1.08%) ▼|BRK-B496.42+8.61 (+1.76%) ▲|C141.90-3.08 (-2.12%) ▼|CAT1,007.50-49.51 (-4.68%) ▼|CL90.79-0.27 (-0.30%) ▼|CMCSA23.18+0.49 (+2.16%) ▲|COF205.01+0.11 (+0.05%) ▲|COP105.29-1.12 (-1.05%) ▼|COST954.42+12.18 (+1.29%) ▲|CRM157.67+7.48 (+4.98%) ▲|CSCO115.96-3.01 (-2.53%) ▼|CVS104.52-0.14 (-0.13%) ▼|CVX170.67-1.57 (-0.91%) ▼|DE626.19-4.57 (-0.72%) ▼|DHR193.81+1.00 (+0.52%) ▲|DIS98.77+0.72 (+0.73%) ▲|DUK127.90+0.79 (+0.62%) ▲|EMR144.22-1.12 (-0.77%) ▼|FDX323.00-6.45 (-1.96%) ▼|GD347.34+2.64 (+0.77%) ▲|GE368.94-2.42 (-0.65%) ▼|GEV1,054.09-31.38 (-2.89%) ▼|GILD126.85+3.01 (+2.43%) ▲|GM78.52-0.01 (-0.01%) ▼|GOOG340.48-1.71 (-0.50%) ▼|GOOGL341.51-2.20 (-0.64%) ▼|GS1,030.82-34.27 (-3.22%) ▼|HD348.34+3.34 (+0.97%) ▲|HON230.53-0.71 (-0.31%) ▼|IBM270.59+12.32 (+4.77%) ▲|INTC128.35-4.53 (-3.41%) ▼|INTU269.61+14.54 (+5.70%) ▲|ISRG404.89+5.20 (+1.30%) ▲|JNJ253.59+8.71 (+3.56%) ▲|JPM330.08-5.04 (-1.50%) ▼|KO82.02+1.60 (+1.98%) ▲|LIN520.15-2.13 (-0.41%) ▼|LLY1,206.45+78.76 (+6.98%) ▲|LMT511.56+6.54 (+1.30%) ▲|LOW221.63-0.31 (-0.14%) ▼|LRCX381.07-20.75 (-5.16%) ▼|MA502.09+13.17 (+2.69%) ▲|MCD268.05+3.51 (+1.33%) ▲|MDLZ61.45+0.25 (+0.41%) ▲|MDT80.81+1.01 (+1.27%) ▲|META555.47+12.60 (+2.32%) ▲|MMM165.31-2.67 (-1.59%) ▼|MO73.40+0.19 (+0.26%) ▲|MRK127.63+2.18 (+1.74%) ▲|MS213.82-7.22 (-3.27%) ▼|MSFT371.69+18.86 (+5.35%) ▲|MU1,152.96-60.60 (-4.99%) ▼|NEE87.81+0.11 (+0.12%) ▲|NFLX73.89+2.99 (+4.21%) ▲|NKE40.96+0.06 (+0.15%) ▲|NOW97.65+8.13 (+9.08%) ▲|NVDA195.23-0.51 (-0.26%) ▼|ORCL150.85-1.61 (-1.06%) ▼|PEP141.32+1.80 (+1.29%) ▲|PFE24.19+0.52 (+2.18%) ▲|PG148.75+0.25 (+0.17%) ▲|PLTR113.72+6.45 (+6.01%) ▲|PM181.08+2.15 (+1.20%) ▲|QCOM197.23-7.68 (-3.75%) ▼|RTX189.39+2.80 (+1.50%) ▲|SBUX104.38+1.22 (+1.18%) ▲|SCHW89.83+0.39 (+0.44%) ▲|SO96.85+0.94 (+0.97%) ▲|SPG226.62+1.13 (+0.50%) ▲|T22.57+0.15 (+0.67%) ▲|TMO504.71-1.04 (-0.21%) ▼|TMUS183.34+1.77 (+0.98%) ▲|TSLA383.64+8.52 (+2.27%) ▲|TXN293.90-17.91 (-5.74%) ▼|UBER76.14+3.89 (+5.38%) ▲|UNH425.04+9.51 (+2.29%) ▲|UNP269.45+1.72 (+0.64%) ▲|UPS108.60-0.72 (-0.65%) ▼|USB61.06-0.16 (-0.25%) ▼|V337.94+7.42 (+2.24%) ▲|VZ46.48+0.41 (+0.89%) ▲|WFC84.74-0.01 (-0.01%) ▼|WMT116.91+1.13 (+0.98%) ▲|XOM136.49-1.06 (-0.77%) ▼|
25.8 C
New York
Friday, June 26, 2026

Tag: volume

newssourceFORcompanyinformationcontent1marketreleases

Workout Routine For Men Revealed: How To Build Muscle Fast With CrazyBulk Muscle Gaining Supplements

Discover the ultimate workout routine for men and learn how to build muscle fast with expert training tips, CrazyBulk stacks, and muscle gaining supplements. Get actionable strategies and science-backed advice for rapid results, maximum strength, and a lean, powerful physique. 
Discover the ultimate workout routine for men and learn how to build muscle fast with expert training tips, CrazyBulk stacks, and muscle gaining supplements. Get actionable strategies and science-backed advice for rapid results, maximum strength, and a lean, powerful physique.

PaxMining Announces Green Cloud Mining Platform — Earn Up to $5,500 Daily as Bitcoin Booms Ahead of 2025

London, UK, July 20, 2025 (GLOBE NEWSWIRE) -- Bitcoin has skyrocketed past $123,000 in July 2025, fueled by BlackRock’s Bitcoin ETF with $3.2 billion in daily trading volume and U.S. regulatory clarity via the CLARITY Act. PaxMining, a global cloud mining leader, empowers investors to seize this rally with its sustainable, AI-driven platform.

Ulanzi Named Global No.1 in Camera Accessories Sales Volume for 2024 by Frost & Sullivan

Ulanzi named world’s top camera accessories brand by sales volume in 2024, driven by innovation, creator-first products, and global digital expansion.

Bad Credit Loan Providers with Guaranteed Approval & No Credit Check: Why MoneyMutual Is the Last One Standing in 2025

In this 2025 report on the best bad credit loan providers with guaranteed approval and no credit check required, we examine how MoneyMutual stands out in a shrinking industry. As other platforms disappear or get flagged for compliance violations, MoneyMutual continues to connect borrowers with fast $500 loans, emergency cash advances, and secure same-day lending access—even for people with low or no credit scores. 
In this 2025 report on the best bad credit loan providers with guaranteed approval and no credit check required, we examine how MoneyMutual stands out in a shrinking industry. As other platforms disappear or get flagged for compliance violations, MoneyMutual continues to connect borrowers with fast $500 loans, emergency cash advances, and secure same-day lending access—even for people with low or no credit scores.

XRP Whales Shift Funds Into VNBTC Cloud Mining Platform For Stable Passive Income

XRP whales channel holdings into VNBTC’s cloud mining platform, unlocking daily passive income through new XRP-enabled Bitcoin and Dogecoin contracts.

RED CAT DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds Red Red Cat Holdings, Inc. Investors of July 22nd Deadline and Urges Them to...

Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Red Cat (RCAT) To Contact Him Directly To Discuss Their Options

XRP Surges Over 20%: JA Mining Unveils Dual-Income Cloud Mining Contracts to Capture Daily Yield and Token Upside

XRP cloud mining platform offers both fixed returns and crypto appreciation amid renewed investor interest 
XRP cloud mining platform offers both fixed returns and crypto appreciation amid renewed investor interest

Grocer Addresses Elevated Pricing—Implications for Cost Management Strategies

In the retail sector, strategic pricing adjustments can significantly impact both consumer satisfaction and competitive positioning. Recently, Jubilee Marketplace in Greenpoint, Brooklyn, exemplified this...

INVESTOR DEADLINE TUESDAY: Red Cat Holdings, Inc. Investors with Substantial Losses Have Opportunity to Lead Investor Class Action Lawsuit – RCAT

SAN DIEGO, July 18, 2025 /PRNewswire/ -- Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Red Cat Holdings, Inc. (NASDAQ:...

Montfort Capital Announces Reinstatement of Trading on TSXV

TORONTO, July 18, 2025 /CNW/ - Montfort Capital Corp. (TSXV:MONT) ("Montfort" or the "Company") is pleased to announce that the TSX Venture Exchange (the...

CRUISE PLANNERS NAMED TO TRAVEL WEEKLY’S 2025 POWER LIST, RANKS #24 AMONG NATION’S TOP TRAVEL AGENCIES

CORAL SPRINGS, Fla., July 18, 2025 /PRNewswire/ -- Cruise Planners, the nation's largest home-based travel franchise network, has once again secured its position among the...

Transaction in Own Shares

Transaction in Own Shares

European Commission Grants Conditional Approval of EZMEKLY® (mirdametinib) for the Treatment of Adult and Pediatric Patients with NF1-PN

– EZMEKLY is the first and only therapy to receive marketing authorization in the EU for both adults and children (≥2 years) with NF1-PN, a rare genetic disorder with debilitating symptoms – 
– EZMEKLY is the first and only therapy to receive marketing authorization in the EU for both adults and children (≥2 years) with NF1-PN, a rare genetic disorder with debilitating symptoms –

European Commission Grants Conditional Approval of EZMEKLY® (mirdametinib) for the Treatment of Adult and Pediatric Patients with NF1-PN

– EZMEKLY is the first and only therapy to receive marketing authorization in the EU for both adults and children (≥2 years) with NF1-PN, a rare genetic disorder with debilitating symptoms – 
– EZMEKLY is the first and only therapy to receive marketing authorization in the EU for both adults and children (≥2 years) with NF1-PN, a rare genetic disorder with debilitating symptoms –

- A word from our sponsors -

spot_img

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsVolume

Explore

Press Releases

News & Opinion

Living

Others

Follow us

© Copyright 2025. BusinessPressWire® / 14 Wall Street New York City NY 10005 +1 888-502-0266 / Disclaimers